Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

LOAG_05396 anticorps

LOAG_05396 Reactivité: Humain, Souris, Rat ELISA, WB, IF Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN4888956
  • Antigène Tous les produits LOAG_05396
    LOAG_05396 (Acetylcholine Receptor Protein (LOAG_05396))
    Reactivité
    Humain, Souris, Rat
    Hôte
    • 3
    Lapin
    Clonalité
    • 3
    Polyclonal
    Conjugué
    • 3
    Cet anticorp LOAG_05396 est non-conjugé
    Application
    • 3
    • 3
    • 2
    • 1
    ELISA, Western Blotting (WB), Immunofluorescence (IF)
    Specificité
    Reacts with human CHRNA1 protein
     Réactivité croisée
    Souris, Rat (Rattus)
    Réactivité croisée (Details)
    Cross reacts with protein from mouse, rat and other species due to sequence homology.
    Purification
    Purified (protein A)
    Immunogène
    Synthetic peptide derived from the human CHRNA1 protein.
  • Indications d'application

    Working dilution: Optimal dilution should be determined by the end user.
    The following are guidelines only :
    IF(1:50 - 1:200) WB(1/200 - 1:1000)

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Must be reconstituted in distilled water.
    Concentration
    1 mg/mL
    Buffer
    Tris 0,1M, glycine 0,1M, sucrose 2 %
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
    Date de péremption
    24 months
  • Antigène
    LOAG_05396 (Acetylcholine Receptor Protein (LOAG_05396))
    Autre désignation
    Acetylcholine receptor protein (LOAG_05396 Produits)
    Synonymes
    anticorps acetylcholine receptor protein, anticorps LOAG_05396
    Sujet
    Belongs to the ligand-gated ion channel family. Acetylcholine receptor subfamily. Alpha-1/CHRNA1 sub-subfamily. Defects in CHRNA1 are a cause of multiple pterygium syndrome lethal type (MUPSL), congenital myasthenic syndrome slow-channel type (SCCMS) and congenital myasthenic syndrome fast-channel type (FCCMS).
    UniProt
    P02708
Vous êtes ici:
Support technique